andrew ip
Hackensack University Medical Center
Hackensack, United States
Review Editor
Hematologic Malignancies
- Frontiers in Oncology
- Hematologic Malignancies
- Editorial Board
Type at least 3 characters
774 editors
Shape the future of research in your field
Join the board
Editors
Review Editors
yazad d irani
South Australian Health and Medical Research Institute (SAHMRI)
Adelaide, Australia
Review Editor
Hematologic Malignancies
sawa ito
National Heart, Lung, and Blood Institute (NIH)
Bethesda, United States
Review Editor
Hematologic Malignancies
komal kumr javarappa
National University of Singapore
Singapore, Singapore
Review Editor
Hematologic Malignancies
ryan jacobs
Levine Cancer Institute
Charlotte, United States
Review Editor
Hematologic Malignancies
deepa jagadeesh
Cleveland Clinic
Cleveland, United States
Review Editor
Hematologic Malignancies
johann christoph jann
Dana-Farber/Brigham and Women's Cancer Center
Boston, United States
Review Editor
Hematologic Malignancies
sabira mohammed jazir
University of Oklahoma Health Sciences Center
Oklahoma City, United States
Review Editor
Hematologic Malignancies
erlie jiang
Institute of Hematology & Blood Disease Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Tianjin, China
Review Editor
Hematologic Malignancies
xiaoyu jiang
University of Miami Health System
Miami, United States
Review Editor
Hematologic Malignancies
victor jimenez-yuste
University Hospital La Paz
La Paz, Spain
Review Editor
Hematologic Malignancies
nisha joseph
Emory University
Atlanta, United States
Review Editor
Hematologic Malignancies
habibe kurt
Harvard University
Cambridge, United States
Review Editor
Hematologic Malignancies
azza mahmoud kamel
Cairo University
Giza, Egypt
Review Editor
Hematologic Malignancies
govind babu kanakasetty
HCG Cancer Hospital
Bengaluru, India
Review Editor
Hematologic Malignancies
malathi kandarpa
University of Michigan
Ann Arbor, United States
Review Editor
Hematologic Malignancies